Archives
Showing 51 - 60 of 76 posts
https://www.coltonconsortium.org/projects/center-of-excellence-for-cell-therapy-in-autoimmunity-cecta/
Advancing engineered CAR and CAAR T cell therapies across multiple autoimmune diseases through clinical trials, preclinical development, and industry partnerships.
https://www.coltonconsortium.org/publications/vessel-wall-mri-in-giant-cell-arteritis-standardized-protocol-and-scoring-approach-developed-by-an-international-working-group/
https://www.coltonconsortium.org/publications/the-2024-vasculitis-foundation-quality-care-summit-seeking-strategies-to-improve-care-for-all-patients/
https://www.coltonconsortium.org/publications/personalized-treatment-decision-algorithms-for-the-clinical-application-of-serum-neurofilament-light-chain-in-multiple-sclerosis-a-modified-delphi-study/
https://www.coltonconsortium.org/publications/psoriatic-arthritis-phenotype-clusters-and-their-association-with-treatment-response-a-real-world-longitudinal-cohort-study-from-the-psoriatic-arthritis-research-consortium/
https://www.coltonconsortium.org/publications/defining-on-treatment-remission-in-plaque-psoriasis-a-consensus-statement-from-the-national-psoriasis-foundation/
https://www.coltonconsortium.org/publications/clinical-and-ultrasound-features-of-a-cohort-of-psoriasis-patients-without-musculoskeletal-symptoms-a-prospective-and-multicenter-study/
https://www.coltonconsortium.org/publications/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-study/
https://www.coltonconsortium.org/publications/comparison-of-eular-printo-pres-ankara-2008-and-2022-acr-eular-classification-criteria-for-granulomatosis-with-polyangiitis-in-children/
https://www.coltonconsortium.org/news/yale-news-spotlights-the-colton-center-as-a-key-driver-of-autoimmune-innovation-at-yale-ventures/
A Yale News feature on Yale Ventures' five accelerator funds highlights the Colton Center for Autoimmunity's growing role in translating autoimmune research into startups, licenses, and real-world therapies.
